<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00587977</url>
  </required_header>
  <id_info>
    <org_study_id>1994-04</org_study_id>
    <secondary_id>2A3360</secondary_id>
    <secondary_id>FAMRI 2</secondary_id>
    <nct_id>NCT00587977</nct_id>
  </id_info>
  <brief_title>Aortic Distensibility</brief_title>
  <acronym>FAMRI</acronym>
  <official_title>ECG-Gated Multidetector CT of Aortic Distensibility FAMRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Flight Attendant Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Can software be developed to automatically aid in the measurement of abdominal aortic
      aneurysms, and is there a way to predict future rupture or growth of abdominal aortic
      aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: ECG-gated multidetector CT and ECG-gated Dual Source CT can be used to create
      multiple volumetric datasets of the abdominal aorta over the time period of the cardiac
      cycle, allowing for direct and regional calculations of abdominal aortic distensibility over
      the entire volume of the abdominal aorta, providing insight into risk of abdominal aortic
      aneurysm rupture and early large vessel stiffness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In year one, this data will be used to develop pulsatility software and test robustness.</measure>
    <time_frame>First Year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>In year two, the time-resolved CT angiographic datasets from each patient will be analyzed to determine peak AAA pulsatility and peak AAA relative pulsatility (to cross-sectional area within the aneurysm).</measure>
    <time_frame>Year Two</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">67</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Aortic aneurysm repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Aortic aneurysm growth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Aortic aneurysm growth stable.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing imaging of their abdominal aortic aneurysm
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AAA must be at least 3 cm to a maximum 4.9cm cross-sectional diameter.

          -  BMI 31 or less.

          -  Creatinine results &lt;2.0 and within six months prior to scan.

          -  US patients must have only normal creatinine (0.9 to 1.4) for one year before study
             visit.

          -  Patients who are originally scheduled for US, who are then subsequently rolled in this
             study, will have only a ultrasound scan as followup after the initial CTA.

        Exclusion Criteria:

          -  Creatinine &gt; 2.0.

          -  Creatinine &lt;0.9 or &gt;1.4 for those who are scheduled for US.

          -  Atrial fibrillation or other arrythmia.

          -  Known AAA greater than 5 cm in size.

          -  Allergy to contrast dye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel G. Fletcher, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic - Rochester, Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.mayo.edu</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <reference>
    <citation>Zhang J, Fletcher JG, Vrtiska TJ, Manduca A, Thompson JL, Raghavan ML, Wentz RJ, McCollough CH. Large-vessel distensibility measurement with electrocardiographically gated multidetector CT: phantom study and initial experience. Radiology. 2007 Oct;245(1):258-66.</citation>
    <PMID>17885194</PMID>
  </reference>
  <reference>
    <citation>Wentz RJ, Manduca A, Fletcher JG, Siddiki HA, Shields RC, Vrtiska TJ, Spencer GC, Primak AN, Zhang J, Nielson TA, McCollough CH, Yu L. SPIE Medical Imaging 2007.: Physiology, Function, and Structure from Medical Images, 2007; 6511:1-9</citation>
  </reference>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2007</study_first_submitted>
  <study_first_submitted_qc>January 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2008</study_first_posted>
  <last_update_submitted>November 7, 2012</last_update_submitted>
  <last_update_submitted_qc>November 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2012</last_update_posted>
  <responsible_party>
    <name_title>Joel Garland Fletcher, M.D.</name_title>
    <organization>Mayo Clinic Rochester, Minnesota</organization>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

